201 related articles for article (PubMed ID: 21622896)
1. Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.
De Silva RA; Peyre K; Pullambhatla M; Fox JJ; Pomper MG; Nimmagadda S
J Nucl Med; 2011 Jun; 52(6):986-93. PubMed ID: 21622896
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of N-[(11)C]methyl-AMD3465 as a PET tracer for imaging of CXCR4 receptor expression in a C6 glioma tumor model.
Hartimath SV; van Waarde A; Dierckx RA; de Vries EF
Mol Pharm; 2014 Nov; 11(11):3810-7. PubMed ID: 25094028
[TBL] [Abstract][Full Text] [Related]
3.
Burke BP; Miranda CS; Lee RE; Renard I; Nigam S; Clemente GS; D'Huys T; Ruest T; Domarkas J; Thompson JA; Hubin TJ; Schols D; Cawthorne CJ; Archibald SJ
J Nucl Med; 2020 Jan; 61(1):123-128. PubMed ID: 31201250
[TBL] [Abstract][Full Text] [Related]
4. Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4).
Woodard LE; De Silva RA; Behnam Azad B; Lisok A; Pullambhatla M; G Lesniak W; Mease RC; Pomper MG; Nimmagadda S
Nucl Med Biol; 2014 Aug; 41(7):552-61. PubMed ID: 25038987
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography imaging of tumors expressing the human chemokine receptor CXCR4 in mice with the use of 64Cu-AMD3100.
Weiss ID; Jacobson O; Kiesewetter DO; Jacobus JP; Szajek LP; Chen X; Farber JM
Mol Imaging Biol; 2012 Feb; 14(1):106-14. PubMed ID: 21347799
[TBL] [Abstract][Full Text] [Related]
6. In vivo Evaluation of an Engineered Cyclotide as Specific CXCR4 Imaging Reagent.
Lesniak WG; Aboye T; Chatterjee S; Camarero JA; Nimmagadda S
Chemistry; 2017 Oct; 23(58):14469-14475. PubMed ID: 28771849
[TBL] [Abstract][Full Text] [Related]
7. Development and Evaluation of an
Brickute D; Braga M; Kaliszczak MA; Barnes C; Lau D; Carroll L; Stevens E; Trousil S; Alam IS; Nguyen QD; Aboagye EO
Mol Pharm; 2019 May; 16(5):2106-2117. PubMed ID: 30883140
[TBL] [Abstract][Full Text] [Related]
8.
Li H; Li X; Sun L; He Y; Wang L; Gao Y; Zeng D; Pang X; Xu J
Bioconjug Chem; 2024 May; 35(5):567-574. PubMed ID: 38634516
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.
Nimmagadda S; Pullambhatla M; Stone K; Green G; Bhujwalla ZM; Pomper MG
Cancer Res; 2010 May; 70(10):3935-44. PubMed ID: 20460522
[TBL] [Abstract][Full Text] [Related]
10. Therapy-Induced Changes in CXCR4 Expression in Tumor Xenografts Can Be Monitored Noninvasively with N-[
Hartimath SV; Draghiciu O; Daemen T; Nijman HW; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2020 Aug; 22(4):883-890. PubMed ID: 31802362
[TBL] [Abstract][Full Text] [Related]
11. N-[
Hartimath SV; Khayum MA; van Waarde A; Dierckx RAJO; de Vries EFJ
Mol Imaging Biol; 2017 Aug; 19(4):570-577. PubMed ID: 27896627
[TBL] [Abstract][Full Text] [Related]
12. Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.
Nimmagadda S; Pullambhatla M; Pomper MG
J Nucl Med; 2009 Jul; 50(7):1124-30. PubMed ID: 19525448
[TBL] [Abstract][Full Text] [Related]
13. Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents.
Lesniak WG; Sikorska E; Shallal H; Behnam Azad B; Lisok A; Pullambhatla M; Pomper MG; Nimmagadda S
Mol Pharm; 2015 Mar; 12(3):941-53. PubMed ID: 25590535
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel
Zhang X; You L; Chen S; Gao M; Guo Z; Du J; Lu J; Zhang X
J Labelled Comp Radiopharm; 2018 May; 61(5):438-446. PubMed ID: 29370457
[TBL] [Abstract][Full Text] [Related]
15. Targeting CAIX with [
Yang X; Zhu H; Yang X; Li N; Huang H; Liu T; Guo X; Xu X; Xia L; Deng C; Tian X; Yang Z
Mol Pharm; 2019 Apr; 16(4):1532-1540. PubMed ID: 30803240
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site-Inhibited Factor VII.
Nielsen CH; Jeppesen TE; Kristensen LK; Jensen MM; El Ali HH; Madsen J; Wiinberg B; Petersen LC; Kjaer A
J Nucl Med; 2016 Jul; 57(7):1112-9. PubMed ID: 27013699
[TBL] [Abstract][Full Text] [Related]
17. High-Contrast CXCR4-Targeted
Kwon D; Lozada J; Zhang Z; Zeisler J; Poon R; Zhang C; Roxin Á; Lin KS; Perrin D; Benard F
Mol Pharm; 2021 Jan; 18(1):187-197. PubMed ID: 33253591
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of an (18)F-labeled pyrimidine-pyridine amine for targeting CXCR4 receptors in gliomas.
Demoin DW; Shindo M; Zhang H; Edwards KJ; Serganova I; Pillarsetty NV; Lewis JS; Blasberg RG
Nucl Med Biol; 2016 Oct; 43(10):606-11. PubMed ID: 27485481
[TBL] [Abstract][Full Text] [Related]
19. A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts.
Azad BB; Chatterjee S; Lesniak WG; Lisok A; Pullambhatla M; Bhujwalla ZM; Pomper MG; Nimmagadda S
Oncotarget; 2016 Mar; 7(11):12344-58. PubMed ID: 26848769
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
